PT1608349E - Sistema de administração oral que compreende um agente antibacteriano e um agente anti-inflamatório - Google Patents
Sistema de administração oral que compreende um agente antibacteriano e um agente anti-inflamatório Download PDFInfo
- Publication number
- PT1608349E PT1608349E PT04757724T PT04757724T PT1608349E PT 1608349 E PT1608349 E PT 1608349E PT 04757724 T PT04757724 T PT 04757724T PT 04757724 T PT04757724 T PT 04757724T PT 1608349 E PT1608349 E PT 1608349E
- Authority
- PT
- Portugal
- Prior art keywords
- agent
- antibacterial
- delivery system
- oral delivery
- inflammatory agent
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 3
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000007892 solid unit dosage form Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/391,196 US20040185009A1 (en) | 2003-03-19 | 2003-03-19 | Composition and device for treating periodontal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1608349E true PT1608349E (pt) | 2008-01-25 |
Family
ID=32987657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04757724T PT1608349E (pt) | 2003-03-19 | 2004-03-17 | Sistema de administração oral que compreende um agente antibacteriano e um agente anti-inflamatório |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040185009A1 (pt) |
| EP (1) | EP1608349B1 (pt) |
| AT (1) | ATE375789T1 (pt) |
| CA (1) | CA2519038A1 (pt) |
| DE (1) | DE602004009552T2 (pt) |
| DK (1) | DK1608349T3 (pt) |
| ES (1) | ES2298787T3 (pt) |
| PL (1) | PL1608349T3 (pt) |
| PT (1) | PT1608349E (pt) |
| WO (1) | WO2004084873A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7972137B2 (en) * | 2003-06-30 | 2011-07-05 | Rosen Gerald M | Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
| FR2896057A1 (fr) * | 2006-01-12 | 2007-07-13 | St Microelectronics Sa | Procede et dispositif de generation d'un nombre aleatoire dans un peripherique usb |
| US20080241795A1 (en) * | 2007-03-26 | 2008-10-02 | Block James C | Prevention and treatment of alveolar osteitis |
| CN101686964A (zh) * | 2007-05-22 | 2010-03-31 | 威斯康星旧生研究基金会 | 基因组维护接口的抗细菌药物靶向 |
| WO2010019549A2 (en) * | 2008-08-12 | 2010-02-18 | Osteogenex Inc | Indoprofen derivatives for promoting bone growth |
| US20100098746A1 (en) * | 2008-10-20 | 2010-04-22 | Warsaw Orthopedic, Inc. | Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
| SG177354A1 (en) | 2009-07-01 | 2012-02-28 | Dexcel Pharma Technologies Ltd | Local therapeutic release device |
| JP5653602B2 (ja) * | 2009-09-02 | 2015-01-14 | 東洋精糖株式会社 | 高吸収性薬剤組成物およびその製造方法 |
| US8865198B2 (en) | 2010-10-25 | 2014-10-21 | Dexcel Pharma Technologies Ltd. | Method for treating a periodontal disease |
| DE102012001978A1 (de) | 2012-02-02 | 2013-08-08 | Voco Gmbh | Dentale Kompositmaterialien enthaltend tricyclische Weichmacher |
| DE102012001979A1 (de) | 2012-02-02 | 2013-08-08 | Voco Gmbh | Härtbares Gemisch umfassend Weichmacher mit einem polyalicyclischen Strukturelement zur Anwendung bei der Herstellung dentaler Werkstoffe |
| EP3119420B1 (en) | 2014-03-20 | 2021-09-22 | Technion Research & Development Foundation Ltd. | Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof |
| RU2652349C1 (ru) * | 2017-03-13 | 2018-04-25 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) | Способ местного лечения воспалительных заболеваний пародонта |
| CN107303218A (zh) * | 2017-04-28 | 2017-10-31 | 上海旷视医疗科技有限公司 | 角/巩膜交联技术的安全控制及效能优化系统 |
| IT201800003872A1 (it) * | 2018-03-22 | 2019-09-22 | Dtech Soc A Responsabilita Limitata | Prodotto per il trattamento terapeutico per la prevenzione e cura di patologie del cavo orale, dei denti e degli impianti dentali |
| DE102019000322A1 (de) | 2019-01-14 | 2020-07-16 | Beuth Hochschule Für Technik Berlin | Polymerzusammensetzung mit antiseptischen Eigenschaften und Verfahren zur Herstellung |
| DE102019000321A1 (de) | 2019-01-14 | 2020-07-16 | Beuth Hochschule Für Technik Berlin | Orale Polymerzusammensetzung mit verzögerter Freisetzung |
| DE102019122174A1 (de) | 2019-08-19 | 2021-02-25 | Voco Gmbh | Dentale polymerisierbare Zusammensetzung auf der Basis kondensierter Silane |
| DE102020007979A1 (de) | 2020-12-29 | 2022-06-30 | Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie | Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59222406A (ja) * | 1983-06-01 | 1984-12-14 | Teijin Ltd | 歯周疾患治療用製剤及びその製造法 |
| US4764377A (en) * | 1983-10-07 | 1988-08-16 | The Forsyth Dental Infirmary For Children | Intra-pocket drug delivery devices for treatment of periodontal diseases |
| US4892736A (en) * | 1983-10-07 | 1990-01-09 | The Forsyth Dental Infirmary For Children | Intra-pocket drug delivery devices for treatment of periodontal diseases |
| IL78826A (en) * | 1986-05-19 | 1991-05-12 | Yissum Res Dev Co | Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom |
| US5002769A (en) * | 1987-03-13 | 1991-03-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions for the sustained-release of chlorhexidine |
| US5160737A (en) * | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
| US5702716A (en) * | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5324520A (en) * | 1988-12-19 | 1994-06-28 | Vipont Pharmaceutical, Inc. | Intragingival delivery systems for treatment of periodontal disease |
| US5236355A (en) * | 1988-12-22 | 1993-08-17 | American Cyanamid Company | Apparatus for the treatment of periodontal disease |
| ATE105177T1 (de) * | 1988-12-22 | 1994-05-15 | American Cyanamid Co | Verfahren zur behandlung von periodontitis durch protrahierte wirkstoffabgabe von arzneimitteln in der zahnhoehle, zusammensetzung davon und vorrichtung zur verabreichung. |
| US5190981A (en) * | 1989-08-17 | 1993-03-02 | Sepracor Inc. | Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease |
| US5308839A (en) * | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| US5242910A (en) * | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
| US5660854A (en) * | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
| US5902110A (en) * | 1995-12-18 | 1999-05-11 | The Block Drug Company | Bone regeneration |
| US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
| KR20010021911A (ko) * | 1997-07-23 | 2001-03-15 | 추후제출 | 구강내에서의 약제의 제어방출용 탄닌산-중합체 조성물 |
| US6197331B1 (en) * | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
| US5980925A (en) * | 1997-12-30 | 1999-11-09 | Ethicon, Inc. | High glycerin containing anti-microbial cleansers |
| ES2219000T3 (es) * | 1998-03-26 | 2004-11-16 | Fujisawa Pharmaceutical Co., Ltd. | Preparacion de liberacion sostenida de un compuesto macrolido. |
| US20010049363A1 (en) * | 1998-05-08 | 2001-12-06 | Warner-Lambert Company | Oral composition containing NSAIDs and essential oils |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
-
2003
- 2003-03-19 US US10/391,196 patent/US20040185009A1/en not_active Abandoned
-
2004
- 2004-03-17 EP EP04757724A patent/EP1608349B1/en not_active Expired - Lifetime
- 2004-03-17 DE DE602004009552T patent/DE602004009552T2/de not_active Expired - Lifetime
- 2004-03-17 CA CA002519038A patent/CA2519038A1/en not_active Abandoned
- 2004-03-17 PL PL04757724T patent/PL1608349T3/pl unknown
- 2004-03-17 AT AT04757724T patent/ATE375789T1/de active
- 2004-03-17 ES ES04757724T patent/ES2298787T3/es not_active Expired - Lifetime
- 2004-03-17 PT PT04757724T patent/PT1608349E/pt unknown
- 2004-03-17 DK DK04757724T patent/DK1608349T3/da active
- 2004-03-17 WO PCT/IL2004/000252 patent/WO2004084873A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20040185009A1 (en) | 2004-09-23 |
| ATE375789T1 (de) | 2007-11-15 |
| DE602004009552T2 (de) | 2008-07-24 |
| EP1608349B1 (en) | 2007-10-17 |
| WO2004084873A1 (en) | 2004-10-07 |
| DE602004009552D1 (de) | 2007-11-29 |
| CA2519038A1 (en) | 2004-10-07 |
| EP1608349A1 (en) | 2005-12-28 |
| ES2298787T3 (es) | 2008-05-16 |
| DK1608349T3 (da) | 2008-02-18 |
| PL1608349T3 (pl) | 2008-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1608349E (pt) | Sistema de administração oral que compreende um agente antibacteriano e um agente anti-inflamatório | |
| BG105857A (en) | Pregelatinized starch in a controlled release formulation | |
| IL139229A0 (en) | Drug delivery system comprising a tightly compacted solid medicament stock | |
| BR9914251A (pt) | Formulações orais de liberação sustentada | |
| HUP0203870A2 (hu) | Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény | |
| BR0115965A (pt) | Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos | |
| AU1079701A (en) | Oral transmucosal drug dosage using solid solution | |
| BR0005938A (pt) | Composição de dosagem oral com libaraçãoprolongada | |
| CA2427227A1 (en) | Lactam compound | |
| IL150895A0 (en) | Oral, nasal and pulmonary formulations of copolymer-1 | |
| EP1658849A3 (en) | therapeutic combinations of antihypertensive and antiangiogenic agents | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| TW200503775A (en) | Pharmaceutical composition and method for treating | |
| CY1107874T1 (el) | Φαρμακευτικh σyνθεση επιβραδυνoμενης αποδεσμευσης φλουβαστατiνης | |
| MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| BRPI0113331B8 (pt) | derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica | |
| BR0014383A (pt) | Composições de liberação controlada compreendendo nimesulida | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| HRP20070188B1 (hr) | Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva | |
| EP1228758A4 (en) | PROHYLACTIC AND THERAPEUTIC AGENTS FOR INFLAMMABLE COLON DISEASES | |
| IL143985A0 (en) | New use of melagatran | |
| AU2003290015A1 (en) | Mastitis treatment | |
| AP1485A (en) | Orally administered controlled delivery system for once daily administration of ciprofloxacin. | |
| ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. | |
| BR0014440A (pt) | Formulações de liberação controlada oral |